Phosphorylation of PKCδ by FER tips the balance from EGFR degradation to recycling

Ana Lonic1,2, Freya Gehling1, Leila Belle1

  • 1Centre for Cancer Biology, An Alliance of SA Pathology and the University of South Australia, Adelaide, South Australia, Australia.

Insights

The FER kinase phosphorylates PKCδ, halting EGFR degradation and promoting receptor recycling. This pathway is dysregulated in triple-negative breast cancer, impacting cell growth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Receptor tyrosine kinase (RTK) signaling termination is crucial for cellular homeostasis.
  • Epidermal Growth Factor Receptor (EGFR) degradation occurs via lysosomes, requiring endosome maturation.
  • The molecular mechanisms controlling the switch from early to late endosomes for EGFR degradation are not fully understood.

Purpose of the Study:

  • To elucidate the role of tyrosine kinase FER and PKCδ in regulating EGFR degradation.
  • To investigate the impact of FER-mediated PKCδ phosphorylation on endosomal trafficking.
  • To explore the relevance of this pathway in triple-negative breast cancer (TNBC).

Main Methods:

  • Phosphorylation site mapping of PKCδ.
  • Endosomal trafficking assays using fluorescently tagged proteins.
  • Western blotting and immunoprecipitation to detect protein interactions.
  • Analysis of patient tumor samples.

Main Results:

  • Tyrosine kinase FER phosphorylates PKCδ at Y374, stabilizing phospho-Y374-PKCδ on endosomes.
  • Phospho-Y374-PKCδ inhibits RAB5 release, preventing late endosome maturation and lysosomal fusion.
  • This leads to reduced EGFR degradation and increased EGFR recycling to the cell surface.
  • PTPN14 dephosphorylates phospho-Y374-PKCδ, facilitating endosome maturation.
  • FER-dependent PKCδ phosphorylation promotes EGFR signaling and anchorage-independent growth in TNBC cells.
  • Elevated phospho-Y374-PKCδ and impaired late endosome maturation are observed in a subset of TNBC patients.

Conclusions:

  • FER-mediated phosphorylation of PKCδ is a critical regulator of EGFR degradation.
  • Dysregulation of the FER-PKCδ-EGFR axis contributes to TNBC progression.
  • Targeting this pathway may offer therapeutic strategies for TNBC.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.3K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
15.4K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K